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Single channel45 has been suggested to play an important role in the early steps of activation of
the nicotinic acetylcholine receptor (nAChR) by acetylcholine. Both macroscopic and single channel currents
were recorded in the slowly desensitizing mutants L248T- and K145A-L248T-α7 receptors expressed in Xe-
nopus oocytes. On ACh-evoked currents, substitution of Lys145 by alanine showed the same effects that in
wild type receptors: moderately decreased gating function and a more-than-expected loss of ACh potency,
thus validating the experimental model. Single channel analysis quantitatively agreed with macroscopic data
and revealed that impaired gating function in the double mutant α7K145A/L248T is the consequence of a
slower opening rate, β. Several nicotinic agonists were also studied, showing important features. Particularly,
dimethylphenylpiperazinium (DMPP), acting as an antagonist in α7K145A, became a full agonist in
α7K145A/L248T. Single channel analysis of DMPP-evoked currents showed effects of Lys145 removal similar
to those observed with ACh. Data suggest that α7Lys145 facilitates the early steps of channel activation.
Moreover, the slowly desensitizing mutant α7L248T could be an interesting tool for the study of channel
activation in α7 receptors. Nevertheless, its extensively altered pharmacology precludes the simple
extrapolation of pharmacological data obtained in singly mutated α7 receptors.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionNicotinic acetylcholine receptors (nAChRs) mediate fast synaptic
transmission in muscle and nerve cells. They are members of the Cys-
loop family of ligand-gated ion channels, which includes 5-HT3,
γ-GABAA receptors, and glycine receptors [1,2]. Such receptors are
allosteric proteins because the signal generated at the binding-site
region must be transmitted to the channel gate located some distance
away, and this process involves a more than local conformational
change [3]. Recent structural data from the Torpedo nAChR [4,5] and
from the acetylcholine binding protein (AChBP) of snails [6,7] have
been helping to understand the coupling between binding and gating
in Cys-loop receptors. However, the precise molecular mechanisms
involved in channel activation are still poorly understood [8].
According to the current model of activation, the interaction of the
agonist with the binding site would generate a motion of the α
subunits that is transmitted to the gate through rearrangements of
several extracellular structures. Among them, the highly conserved
Lys145, at the β-strand β7 of nAChRα subunits, is located close to both
the Cys-loop and the binding segment C, the latter containing several
aromatic residues involved in binding of nicotinic agonists and4 965919561.
ll rights reserved.antagonists [6,9]. Such a unique position and its possible role in
binding–gating coupling had been pointed out after analysis of
crystallographic data obtained in the snail AChBP [10]. This role was
conﬁrmed in both muscle- and neuronal-type α7 nAChRs [11,12]. In
addition to its role in coupling, it has been reported that Lys145 also
determines the pharmacological proﬁle of homomeric α7 nAChRs
because DMPP can become a competitive antagonist after mutating
Lys145 [12].
However, neuronal type α7 nAChRs currents show fast desensi-
tization which precludes the use of single channel data to study the
mechanisms altered by mutations in Lys145 more precisely. The
alternative used in the present work is to include such mutations in a
slowly- or non-desensitizing α7 nAChR, as it is α7L248T nAChR. In
such receptors, a highly conserved leucine residue of the pore domain
has been substituted by a threonine, and the resulting receptors did
not show the typical fast desensitization of homomericα7 nAChR [13],
and also presented an unconventional pharmacology [14–17]. This
non-desensitizing receptor has also been helpful in establishing the
role of several residues both in coupling and calciummodulation ofα7
nAChR [18,19].
In the present work, we have further studied the role of Lys145 in
binding–gating coupling of neuronal typeα7 nAChRs by including the
mutation K145A in α7L248T nAChR, and recording agonist-activated
single channel currents. Our data show that impairment of coupling
was mostly due to a delay in the channel activation. Moreover,
α7L248T nAChRs has been proven to be a useful tool for studying at
Scheme 1.
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nAChRs. However, the pharmacological proﬁle of single mutant
α7K145A could not be transferred to α7L248T nAChRs.
2. Materials and methods
2.1. Generation of mutants of the bovine α7 subunit
The bovine α7 cDNA was cloned in a derivative of the pSP64T
vector [20] containing part of the pBluescript polylinker. To generate
the mutants we annealed single-stranded oligonucleotides with the
desired sequences and proper single-strand ends that could be easily
ligated to the ends generated through restriction enzymes digestion of
the α7 cDNA. The restriction enzyme sites for cloning the annealed
oligonucleotides were either present in the original cDNA sequence or
introduced as silent mutations [21] by using mutated oligonucleotides
and PCR (25 cycles at 94 °C for 10 s, 60 °C for 30 s, 72 °C for 45 s).
2.2. Oocyte expression
Capped mRNAwas synthesized in vitro using SP6 RNA polymerase,
the mMESSAGE mMACHINE kit (Ambion, Texas) and the pSP64T
derivative mentioned above. Defoliculated Xenopus laevis oocytes
were injected either with 2.5 (α7K145A/L248T) or 0.5 (α7L248T) ng of
total cRNA in 50 nl of sterile water. Oocytes were incubated in calcium-
free medium containing 1 μM methyllycaconitine (MLA). All experi-
ments were performed within 3–4 days after cRNA injection.
2.3. 125I-α-bungarotoxin binding assays
Speciﬁc surface expression of 125I-α-bungarotoxin (α-Bgt) binding
sites was tested with 10 nM 125I-α-Bgt as described [22]. Brieﬂy,
oocytes located in 24-well plates were preincubated for 15 min with
Barth's buffer containing 5% of fetal calf serum and further incubated
in the same medium with 10 nM 125I-α-Bgt for 2 h at 18 °C in a ﬁnal
volume of 300 μl. At the end of the incubation, unbound 125I-α-Bgt
was removed, oocytes were passed to 6-well plates, washed ﬁve times
with 4 ml Barth's buffer and bound radioactivity was counted.
Dissociation constants of 125I-α-Bgt were 3.8 and 2.9 nM for α7L248T
and α7K145/L248T, respectively (not signiﬁcant) and, therefore, the
errors derived from not using a saturating concentration should be
small. Nonspeciﬁc binding was determined using uninjected oocytes.
2.4. Electrophysiological recordings
Electrophysiological recordings of whole-cell currents were done
as described previously [22]. Some oocytes showed holding currents
which were mostly blocked by 1 μM MLA suggesting spontaneous
activity of nAChRs. In order to simplify the analysis, oocytes showing
holding currents N1% of the maximal ACh-evoked currents were
discarded. Extracellular solution contained (inmM): NaCl 82.5, KCl 2.5,
BaCl2 2.5, MgCl2 1 and HEPES 5 (pH 7.4). The velocity of application of
agonists was 18–22 ml min−1. All experiments were done at room
temperature (22 °C). Unless otherwise indicated, oocyte membrane
potential was held at −40 mV. Data analysis was performed with the
software package Prism 4.0 (GraphPad Software Inc., San Diego, CA,
USA). Dose–response curveswereﬁtted using a nonlinear least squares
algorithm to the Hill equation, I/Imax=1/(1+(EC50 /C)h), were EC50 is
the agonist concentration that elicits the half-maximal response, h is
the Hill coefﬁcient, and C is the agonist concentration.
Single channel records were obtained in the cell-attached mode
using an Axopatch 200A ampliﬁer (Axon Instruments, CA). Oocytes
were stripped of their vitelline membrane by immersing them in a
hypertonic solution to shrink them enough so that the vitelline
membrane was visible and then could be removed with thin tip
tweezers. They were then transferred to a recording chamber with amodiﬁed extracellular solution where NaCl was substituted by KCl to
clamp the membrane potential close to 0 mV [23]. Holding potential
was −80 mV. Patch pipettes were pulled from thick-walled borosili-
cate glass (GC150-15, Clark Electromedical Instruments), with a
resistance between 5 and 10 MΩ when ﬁlled with standard
extacellular solution. ACh or DMPPwere added to the pipette solution.
Initially 10 μM gadolinium was added to the pipette to block stretch
activated channels [24], but in later experiments gadolinium was not
used because stretch activated channels were not observed if the
negative pressure was released after making the seal and, further-
more, nicotine activated receptors could be recognized by their
kinetics (long openings) and conductance range (with large and
uniform currents). Records were low-pass ﬁltered at 1 kHz with an 8-
pole Bessel ﬁlter (Frequency Devices, Inc.), sampled at 20 kHz and
stored on hard disk for later analysis.
2.5. Data analysis
Single channel recordings were analyzed with the Clampﬁt 9
(Molecular Devices) and the QUB software suite (version 1.4.0.2) [25].
For each patch a voltage pulse protocol was applied to determine the
conductance (γ) and reversal potential (Vr) of the channels. Ten
second duration pulses were applied from +60 to −120 mV at 20 mV
intervals. Single channel current–voltage curves were ﬁtted with
Prism 4 (GraphPad Software, Inc.) to the equation I=γ (V−Vr). Open
probabilities were estimated from all point histograms ﬁtted to a sum
of Gaussians with Clampﬁt routines.
Kinetic analysis was performed using QUB on records with a dead
time of 0.1 ms, idealized by the half amplitude threshold method, and
restricted to bursts of activity of a single channel. Bursts were
identiﬁed by a closed interval longer than a given burst terminator
time that usually was between 10 and 30 ms, and containing more
than 3 opening events. The selected region of the idealized data,
obtained as described above, was then ﬁtted to a simple linear three-
state model with two closed and one open state, with four kinetic
constants, as shown in kinetic Scheme 1, with the MIL method that
gives directly an estimate of the kinetic constants their standard
errors. Dwell time histograms with the corresponding time constants,
and their relative weight, were also obtained with the same program.
Data are presented as mean±standard error. Statistical signiﬁcance
was calculated by non-paired Student's t-test. EC50 values were
comparedwith an F test. The null hypothesiswas rejectedwhen pb0.05.
3. Results
3.1. Effect of the mutation K145A on the functional responses to ACh in
the slowly desensitizing L248T receptor
Fig. 1A shows two families of macroscopic inward ACh-evoked
currents in the single (α7L248T) and double (α7K145A/L248T) mutant
receptors, respectively. Inward currents evoked at equiactive ACh
concentrations presented the same kinetics both in α7L248T and
α7K145A/L248T receptors. Maximal currents in α7K145A/L248T were
almost 2-fold larger than in α7L248T. However, surface expression, as
measured by α-bungarotoxin (α-Bgt) binding, was also increased
around 4-fold.α7L248Tandα7K145A/L248Toocytes expressed 0.5±0.1
and 1.8±0.4 fmol of α-Bgt, respectively (n=4). Nevertheless, such a
difference does not point to a more efﬁcient surface expression of
α7K145A/L248T receptors because of the differences in the amount of
Fig. 2. Acetylcholine-evoked unitary currents. Top panels: Representative traces of
single channel currents evoked by 100 μM ACh in α7L248T and α7K145A/L248T
receptors. Bottom panels: Expanded scale representations of the horizontal bars in top
panels. Holding potential was −100 mV.
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to surface expression, α7K145A/L248T receptors showed a gating
function of 41±12% of α7248T receptors (n=4). This reduction in
gating function is close to that obtained after the inclusion of the same
mutation in wild type α7 receptors [12]. Concentration–responses
relationship in α7L248T receptors showed the typical reduction in the
EC50 value with respect to wild type receptors (around 60-fold lower).
However, α7K145A/L248T receptors showed a shift in ACh potency
similar to that observed when starting with α7 wild type receptors,
because EC50 value increased from 0.65 to 15.7 μM (Fig. 1B). As
occurred in wild type receptors, this change in the EC50 value is not
quantitatively predicted by only considering the modiﬁcation in gating
function. Thus, a change in the ACh binding properties is likely to have
taken place as well.
We have also explored the possible functional interaction between
residues located at positions of Lys145 and Leu248 by calculating the
coupling coefﬁcient Ω of the two-mutant cycle [12,26,27]. Ω values
were 0.42 and 0.57 for the current–binding ratio and for the EC50,
respectively, suggesting that both positions are only weakly coupled,
and thus, effects of mutating Lys145 are not only qualitatively, but also
quantitatively similar in both α7 wild type and α7L248T receptors.
3.2. Acetylcholine-evoked unitary currents in single and double mutants
So far, substitution of Lys145 by alanine showed the same effects in
α7L248T than in α7 wild type receptors. The slowly desensitizing
properties of single mutant α7L248T allowed the acquisition of singleFig. 1. A comparison between the ACh responses of α7L248T nAChR and double mutant
α7K145A/L248T. (A) Inward currents obtained upon stimulation with ACh of α7L248T
(top, control) andα7K145A/L248T (bottom) nAChRs. Traces represent currents obtained
at −40 mV. For each family of currents, ACh concentrations were (from top to bottom):
0.1, 0.3, 1, 3 and 10 μM (α7L248T), and 1, 3, 10, 30 and 100 μM (α7K145A/L248T). (B) ACh
concentration–response curves of oocytes expressing αL248T (ﬁlled circles) and
α7K145A/L248T receptors (open circles). Data are normalized to the estimated maximal
response to ACh (both receptors) and corrected for different surface expression
(α7K145A/L248T receptors, error included). Data points represent means±SEM
obtained in 8–16 oocytes from 3–4 donors. Error bars shown if bigger than symbols.
Continuous lines represent ﬁts of data to the Hill equation.α7L248T: EC50=0.65±0.07 μM,
h=1.51. α7K145A/L248T: EC50=15.6±1.3 μM, h=1.36.channel recordings in the cell-attached conﬁguration of the patch-
clamp technique. In the absence of agonistα7L248T receptors showed
very brief spontaneous openings. However, when the oocyte mem-
brane is exposed to a high ACh concentration (100 μM) large and
frequent unitary inward currents of about 12 pA are observed with
both receptors (Fig. 2). Differences in single channel conductances
were small but signiﬁcant (105±3 and 114±2 pS in α7L248T and
α7K145A/L248T receptors, respectively). However, these results
discard that reduced gating function in α7K145A/L248T was due to
a decrease in the unitary conductance. Very brief events with a smaller
conductance could also be seen in both receptors, but they contribute
very little to the overall probability and were not included in the dwell
time analysis. α7K145A/L248T receptors show both longer closings
and somewhat shorter openings than α7L248T receptors. Single
channels showed open probabilities of 0.17 and 0.06 in α7L248T and
α7K145A/L248T receptors, respectively. Those probabilities were
estimated from ﬁtting all-points histograms with Gaussian functions
and comparing the areas. The estimated ratio of open channel
probabilities (35% of α7L248T receptors) is close to that obtained
previously from macroscopic currents.
Dwell time analysis was also carried out inα7L248T andα7K145A/
L248T receptors. Fig. 3 shows the analysis of two representative
membrane patches. These data could be analyzed in terms of a given
kinetic model. For the sake of simplicity, a simple linear three-state
kinetic model (two closed states and one open state; Scheme 1) was
applied to data, and open time distributions were ﬁtted with mean
open times of 28 and 19 ms, for α7L248T and α7K145A/L248T
receptors, respectively (Table 1). Such a difference was not statistically
signiﬁcant. Accordingly with Scheme 1, closed times showed a two-
exponential distribution with mean closed times of 1.0 (weight: 0.78),
and 31 ms in α7L248T receptors, with a clear dominance of the
shortest closures. When the same analysis is performed in α7K145A/
L248T receptors, mean closed times were longer (1.6 (weight: 0.45),
and 62 ms), and longer closures were much more frequent (Table 1).
Values for the several ﬁrst order kinetic rates could be estimated as
well (Table 2). Such analysis revealed that the reduction in open
probability in α7K145A/L248T receptors is mostly attributed to an
impairment of channel opening due to statistically signiﬁcant decrease
in the opening rate constant, β, being all other rate constants not
statistically different from α7L248T receptors. Interestingly, the gating
constant, β/α, in α7K145A/L248T receptors was 30% of α7L248T
Table 2
Kinetic parameters estimated from a ﬁt to Scheme 1
Agonist Receptor K12 K21 β α β/α
Ach α7L248T 55±17 274±109 863±92 43±7 24±5
α7K145A/L248T 54±14 730±272 474±96⁎ 86±21 7.3±1.8⁎
DMPP α7L248T 119±42 1081±642 1168±177 813±294 1.8±0.5
α7K145A/L248T 68±3 172±75 692±87⁎ 1129±251 0.6±0.1⁎
Data analyzed and agonist concentrations are as in Table 1. Rate constants are in s−1.
⁎ Statistically different from α7L248T (pb0.05).
Fig. 3. Dwell-time histograms of acetylcholine-evoked single channel events. Closed
(left) and open (right) time histograms for α7/L248T (top) and α7K145A/L248T
(bottom) ACh-evoked unitary currents. Logarithmic binning and linear scale for relative
frequency of events were used. Superimposed continuous lines are ﬁts for Scheme 1.
Holding potential was −100 mV.
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account for most of the reduction in overall currents. Taken together,
data suggest that the reduction of whole-cell currents in α7K145A/
L248T receptors is mainly caused by impairment in the channel
activation rather than a destabilization of the open conﬁguration.
3.3. Pharmacological proﬁle
Several mutations of Lys145 in wild type receptors induced
changes in the pharmacological proﬁle of the resulting receptors
[12]. Therefore, we checked the functional responses of α7L248T and
α7K145A/L248T receptors to several nicotinic drugs. All additional
agonists tested evoked ionic currents that were kinetically indis-
tinguishable from ACh-evoked currents both in α7L248T and in
α7K145A/L248T receptors (not shown). Fig. 4 shows concentration–
response relationship for nicotine, epibatidine, cytisine and DMPP.
When compared to α7L248T curves, those obtained with α7K145A/
L248T receptors were consistently shifted to the right, showing
statistically signiﬁcant higher EC50 values. When the same mutation
was inserted inwild type α7 receptors, there were also changes in the
agonist potency, but they were small except for ACh. However, the
shifts observed in the present work were not always of the sameTable 1
Time constants extracted from the dwell-time distributions
Agonist Receptor τc1 (weight) τc2 τo N
Ach α7L248T 0.97±0.13 (0.78±0.08) 31.5±5.9 28.0±4.6 6
α7K145A/L248T 1.62±0.52 (0.45±0.08) 62.4±12.8 18.5±4.9 8
DMPP α7L248T 0.75±0.23 (0.55±0.14) 19.9±2.4 1.94±0.49 5
α7K145A/L248T 1.51±0.25 (0.76±0.05) 15.5±2.7 1.05±0.24 6
Agonist concentrations used were 100 and 10 μM for ACh and DMPP, respectively. Time
constants are in ms. N stands for the number of patches analyzed.magnitude but strongly depended on the agonist used. The loss of
potency in α7K145A/L248T receptors ranged from 1.8-fold with
epibatidine up to 125-fold with cytisine. Nicotine and DMPP showed
in-between values, similar to those obtained with ACh (Fig. 1). When
maximal currents were considered, all tested agonists showed the
same extent of functional response when compared to ACh in the
same receptor (Fig. 5). Only cytisine in α7L248T receptors showed a
small but statistically signiﬁcant reduction inmaximal currents. This is
in great contrast to results obtained with α7 wild type and α7K145A
receptors [12]. In α7 wild type receptors, all ﬁve agonists evoked
similar responses and, when Lys145 was substituted by Ala, responses
to epibatidine and cytisine were only moderately reduced, ACh and
nicotine were signiﬁcantly less efﬁcacious, and DMPP became a
competitive antagonist. The same behavior of DMPP was observed
with carbamylcholine, which was ineffective in the single mutant
α7K145A, but evoked full responses in the double mutant α7K145A/
L248T (not shown).
Competitive nicotinic antagonists and other non-nicotinic drugs
have been reported to activate α7/L248T receptors. Thus, we checked
whether the double mutant α7K145A/L248T retained these unusualFig. 4. Concentration–response relationships. Agonist concentration–response curves of
oocytes expressingα7L248T (ﬁlled circles) andα7K145A/L248T (open circles) nAChRs for
nicotine, epibatidine, cytisine and DMPP. For each receptor and agonist, data are
normalized to their maximal response. Data points represent means±SEM obtained in
4–7 oocytes from 3 donors. Error bars shown if bigger than symbols. Continuous lines
represent ﬁts of data to the Hill equation. Nicotine=0.32±0.07 μM, h=1.06; Nicotine
—α7K145A/L248T: EC50=16.7±1.6 μM, h=1.58. Epibatidine—α7L248T: EC50=0.031
±0.004 μM, h=1.27; Epibatidine—α7K145A/L248T: EC50=0.057±0.006 μM, h=1.29.
Cytisine—α7L248T: EC50=0.035±0.007 μM, h=1.39; Cytisine—α7K145A/L248T:
EC50=4.38±0.29 μM, h=1.51. DMPP—α7L248T: EC50=0.077±0.016 μM, h=0.97; DMPP
—α7K145A/L248T: EC50=1.61±0.11 μM, h=1.98.
Fig. 5.Maximal currents. Meanmaximal currents±SEM upon stimulationwith nicotinic
agonists in α7L248T (ﬁlled bars) and α7K145A/L248T receptors (open bars). Inward
currents were obtained at −40 mV with saturating concentrations of each agonist, and
normalized to the maximal response achieved by ACh in the same oocyte. Data of
α7K145A/L248T receptors were corrected for different surface expression of receptors.
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strychnine and serotonin, all of them were capable to elicit agonist
responses in this double mutant (not shown).
3.4. DMPP-evoked unitary currents in single and double mutants
Since DMPP was able to activate nicotinic currents in α7K145A/
L248T receptors to the same extent than ACh, DMPP-evoked single
channel currents were recorded in the cell-attached conﬁguration
(Fig. 6). Unitary conductances were similar to those observed with
ACh. For DMPP-evoked currents, they were estimated in 102±9 and
114±13 pS, in α7L248T and α7K145A/L248T receptors, respectively
(not signiﬁcant difference). Open probabilities were estimated to be
0.16 and 0.07, very close to those of ACh and in good agreement with
macroscopic data. However, both α7L248T and α7K145A/L248T
receptors also showed several signiﬁcant differences regarding the
activating agonist. First of all, DMPP-evoked openings are much
shorter and, besides, a subconductance state makes a clear contribu-
tion to the total current (Fig. 6).
Dwell time distributions were also analyzed (Fig. 7). According to
Scheme 1, DMPP-activated channels in α7L248T receptors showed
mean open times of 1.9 ms (Table 1), more than one order ofFig. 6. DMPP-evoked unitary currents. Top panels: Representative traces of single
channel currents evoked by 10 μM DMPP in α7L248T and α7K145A/L248T receptors.
Bottom panels: Expanded scale representations of the horizontal bars in top panels.
Holding potential was −100 mV.magnitude shorter than with ACh. Closed times were also briefer (0.8
(weight: 0.55), and 20 ms), but the difference with ACh was not large.
However, in α7K145A/L248T receptors, DMPP evoked slightly shorter
openings (mean open time of 1.1 ms, not signiﬁcant difference), but
the brief closures were longer and more abundant than in α7L248T
receptors (mean closed times of 1.5 (weight: 0.76), and 16 ms). Thus,
the effects of mutating Lys145 to Ala in α7L248T are similar for both
agonists. This could also be observed in the estimates for the ﬁrst-
order rate constants shown in Table 2. Similarly to ACh, opening rate
constant, β, was signiﬁcantly slower in α7K145A/L248T receptors.
However, gating constant, β/α, obtained with DMPP in α7K145A/
L248T receptors was 33% of α7L248T receptors, quantitatively
accounting for the reduction in open channel probability.
4. Discussion
When ACh was used as the activating molecule, the effects of
mutation K145A in α7L248T receptors were similar to those observed
in wild type α7 nAChRs [12], i.e.: a decrease in gating function
(estimated by the current-to-binding ratio) accompanied by a shift to
the right in the dose–response curve which cannot be quantitatively
accounted for by the reduced gating function [28]. Single channel
events were recorded in the presence of nicotinic agonists showing a
unitary conductance around 110 pS, which roughly doubles those
reported for chicken α7-L247T [17] and human α7-L248T receptors
[29]. The higher conductance observed here is likely to be due to a
different gating mode found in bovine α7L248T receptors, rather than
to the simultaneous activation of two lower conductance channels,
because of two reasons: 1st) microscopic kinetics are slower [29], and
2nd) not half-conductance events were recorded.
ACh was applied at saturating concentrations and α7K145A/L248T
receptors showed slightly shorter openings and considerably longer
closings, when compared α7L248T receptors. When studied under aFig. 7. Dwell-time histograms of DMPP-evoked single channel events. Closed (left) and
open (right) time histograms for α7/L248T (top) and α7K145A/L248T receptors
(bottom) DMPP-evoked unitary currents. Logarithmic binning and linear scale for
relative frequency of events were used. Superimposed continuous lines are ﬁts for
Scheme 1. Holding potential was −100 mV.
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resulted in changes of the opening rate constant (β).These results are
in qualitative agreement with those obtained in muscle nAChRs
showing that substitution of Ala for αK145 intensely affected receptor
activation mostly by a large reduction in opening rate constant [11].
Thus, data conﬁrm that Lys145 is involved in the early steps of muscle
nAChR activation, as could have been advanced by the strategic
position of Lys145. However, the effects of mutating Lys145 in
neuronal-type α7L248T receptors are more modest, which is not
surprising because both quantitative and qualitative discrepancies
between muscle- and neuronal-type nAChR gating have been
reported [12,21,27,30,31].
Several residues and/or regions of the extracellular domain of
neuronal-type subunits have been identiﬁed as determinants of
pharmacological selectivity in nAChRs [32–37]. The pharmacological
proﬁle of α7 AChRs is also determined by the residue present at
position 145. Thus, singlemutantα7K145A showed a great inﬂuence in
the effectiveness of some nicotinic agonists (ACh, nicotine, carbamyl-
choline and DMPP), but not others (cytisine, epibatidine), being the
most remarkable changes those of carbamylcholine and DMPP, which
became competitive antagonists in mutant α7K145A [12]. We have
checked the effectiveness and potency of those nicotinic agonists in
both α7L248T and α7K145A-L248T receptors, and found that they
behaved as full agonists in both receptors. This was not absolutely
unexpected asα7L248T receptors have been shown to present a rather
peculiar pharmacology, capable of being activated by a series of typical
nicotinic antagonists such as tubocurarine, dihydro-β-erithroidine,
hexamethonium, serotonine, strychnine or bicuculine [14–16,29]. All
the latter were also able to activate the doubly mutated α7K145A/
L248T receptors. Moreover, changes in the potency of the conventional
agonists tested were much larger than those observed in the single
mutant α7K145A. All these data indicate that the pharmacological
phenotype of single mutant α7K145A cannot be transferred to
α7L248T receptors, probably because the gating mechanisms of
α7L248T receptors are deeply altered. Whatever the case, we have
also explored the effects of the K145A mutation on DMPP-activated
single channel currents. Although open channel block cannot be ruled
out (DMPP is used at saturating concentrations), single channel
currents activated by DMPP greatly differed from those by ACh.
Openings are much shorter, gating constants, β/α, are much smaller
and several subconductance states might signiﬁcantly contribute to
the overall current. Nevertheless, it should be pointed out that single
channel analysis was performed only on the higher conductance
openings. This bias and the one originated by the method of selecting
the bursts of activity,which excludes very long closures (more frequent
withACh), could partially explain that the quantitative agreementwith
macroscopic currents data is not complete. However, the effect of
substituting Lys145 by Ala is roughly similar to that obtained by ACh:
i.e.: closings are longer and openings are slightly shorter in α7K145A/
L248T receptors, both resulting in a reduced open probability.
At the single channel level the present work has addressed the
mechanism bywhich Lys145 is involved in the gating of neuronal-type
homomeric α7 nAChRs [12] by using the non-desensitizing α7L248T
receptor as control. In spite of some quantitative differences, results
are similar to those obtained in muscle-type nAChRs, showing that
Lys145 is involved in the early steps of channel activation, and
suggesting again that the coupling between agonist binding and
gating could depend on the type of nAChR studied. Nevertheless, the
otherwise deeply altered gating of α7L248T receptors precludes the
direct extrapolation of pharmacological data obtained in singly
mutated α7 receptors.
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